Immungenetik

Programme

• 15:30 – 16:00 25 Min. 5 Min.

  • Vortrag (online)
  • VS-16-1

  HLA-DQA/DQB permissiveness in stem cell transplantation

  • MD Effie Wang Petersdorf (Seattle, WA / US)

  
• 16:00 – 16:10 6 Min. 4 Min.

  • Abstractvortrag
  • VS-16-2

  Higher risk for chronic graft-versus-host disease (GvHD) in HLA-G mismatched transplants following allogeneic hematopoietic stem cell transplantation (allo-HSCT)

  • Christine Neuchel (Ulm / DE)

   8. Immungenetik: HLA und Transplantationen
• 16:10 – 16:20 6 Min. 4 Min.

  • Abstractvortrag
  • VS-16-3

  The alloCELL program: Patient monitoring, donor selection and GMP-compliant manufacturing of virus-specific T cells from stem cell, family and third-party T-cell donors

  • Prof. Dr. Britta Eiz-Vesper (Hannover / DE)

   12. Zelltherapie und Gentherapie, 8. Immungenetik: HLA und Transplantationen
• 16:20 – 16:30 6 Min. 4 Min.

  • Abstractvortrag
  • VS-16-4

  Genetically engineered lungs are protected from immune rejection in the absence of immunosuppression

  • Prof. Constanca Figueiredo (Hannover / DE)

   12. Zelltherapie und Gentherapie, 8. Immungenetik: HLA und Transplantationen